“…In addition to other members of the Anoctamin family (Table 1) Amplification and overexpression of ANO1 in different cancerous tissues have been confirmed; however, there is no strong evidence on how cell proliferation and migration could be related to ANO1 overexpression. Antagonists of CaCCs can be investigated to see their therapeutic potentials via apoptosis of cancer cells as recently suggested in different studies (Guan, Song, Gao, Gao, & Wang, 2016;Jia, Liu, Guan, Lu, & Wang, 2015;Musrap et al, 2015). Furthermore, the crystallography studies in higher resolutions, in combination with bioinformatics approaches, can help us decipher the proper gating, voltage, and calcium sensitivity of these channels that can be of great value in designing novel therapeutic drugs.…”